Todays Top RNS's from Vox Markets: J D Wetherspoon, Blencowe Resources, ASOS & More

Wetherspoon (JD) PLC - Interim Results

J D Wetherspoon reports a revenue increase of 3.9% to £1,029.5m, despite a 4.3% decrease in operating profit due to higher labour and utility costs. Like-for-like sales grew by 4.8%, and a 4.0p interim dividend was declared. The Chairman highlighted industry challenges, such as increased costs and VAT disparities with supermarkets.

Blencowe Resources - ESIA Approval

Blencowe Resources has received approval for a revised Environmental, Social, Impact Assessment (ESIA) for its Orom-Cross Graphite Project in Uganda. Key enhancements include tripled production rates, sustainable tailings disposal, and hydropower integration. 

ASOS PLC - Notice of Results and Trading Update

ASOS Plc will release its H1 FY25 results on 24 April 2025, anticipating significant profitability improvements. The growth is driven by a strong gross margin, reduced markdowns, and a more robust full-price mix. Revenue growth aligns with consensus, and adjusted EBITDA surpasses expectations. ASOS’s Test & React model has boosted own-brand full-price sales.

Helium One Global Ld - Unaudited Interim Results

Helium One Global Limited reports a net cash balance of $10.02 million, driven by successful helium exploration in Tanzania and a 50% interest acquisition in the USA's Galactica-Pegasus project. Despite losses, the company shows potential for near-term revenue from its projects, bolstering its strategic position in the helium market.

Citius Resources PLC - First Day of Dealings

Citius Resources PLC has completed its acquisition of Harena Resources Limited, resulting in a name change to Harena Resources PLC. The company begins trading on the London Stock Exchange under the ticker HREE. Harena owns 75% of the Ampasindava Ionic Clay Rare Earth Project in Madagascar, a significant asset for military, AI, and renewable energy applications.

Angle PLC - Results of Eisai Phase 2 pilot study

ANGLE plc announces successful completion of AstraZeneca's AR and DDR assay development projects, enhancing CTC analysis in oncology. Results from Eisai's Phase 2 study validate ANGLE's HER2 assay for dynamically assessing breast cancer patient HER2 status, advancing the potential for HER2-ADC trials. ANGLE seeks collaboration with BlissBio for BB-1701's next development stage.

hVIVO PLC - Notice of Results

hVIVO plc, a leading Contract Research Organisation in human challenge clinical trials, will release its final results for 2024 on April 10, 2025. The company, known for its extensive clinical development services, will host analyst and investor briefings on the same day, featuring CEO Yamin 'Mo' Khan and CFO Stephen Pinkerton.

Power Metal Res. - Uranium JV: Reitenbach Exploration Update

Power Metal Resources PLC reports promising findings from the Reitenbach Uranium Property. Geophysical surveys and fieldwork identified multiple potential uranium sources, supported by radon and lead isotope results. With a 27.5% property expansion and upcoming drilling, the company anticipates significant exploration advancements in 2025.

Ceres Power Holdings - Final results for the year ended 31 December 2024

Ceres Power Holdings reported record figures for 2024, with revenue at £51.9 million and significant new partnerships with Delta Electronics, Denso, and Thermax Ltd. Challenges included the termination of a Bosch contract, but the company's 2025 outlook remains strong, focusing on commercializing solid oxide technologies and expanding its global partner network.

OPG Power Ventures - Trading Update

OPG Power Ventures Plc reports a stable FY25 performance with a PLF of 69.6% and aligns with market EBITDA expectations. India's power sector growth, a debt reduction strategy, coal supply contracts, and directorate changes mark significant developments. OPG is also exploring investments with state governments and cooperates in a regulatory investigation.